BlackRock Health Sciences Term Trust (NYSE:BMEZ) Shares Bought by Brown Lisle Cummings Inc.

Brown Lisle Cummings Inc. lifted its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 6.2% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 36,513 shares of the company’s stock after acquiring an additional 2,128 shares during the quarter. Brown Lisle Cummings Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $578,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of BMEZ. Dakota Wealth Management increased its stake in BlackRock Health Sciences Term Trust by 5.3% during the 2nd quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock worth $280,000 after buying an additional 915 shares during the period. Benjamin F. Edwards & Company Inc. grew its stake in shares of BlackRock Health Sciences Term Trust by 21.7% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock valued at $96,000 after acquiring an additional 1,038 shares in the last quarter. Kingswood Wealth Advisors LLC increased its position in shares of BlackRock Health Sciences Term Trust by 9.2% during the first quarter. Kingswood Wealth Advisors LLC now owns 21,988 shares of the company’s stock worth $360,000 after acquiring an additional 1,845 shares during the last quarter. Comerica Bank increased its position in shares of BlackRock Health Sciences Term Trust by 31.1% during the first quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after acquiring an additional 3,671 shares during the last quarter. Finally, PNC Financial Services Group Inc. lifted its stake in shares of BlackRock Health Sciences Term Trust by 17.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 30,559 shares of the company’s stock worth $448,000 after acquiring an additional 4,604 shares in the last quarter.

Insider Transactions at BlackRock Health Sciences Term Trust

In related news, major shareholder Saba Capital Management, L.P. purchased 15,455 shares of the business’s stock in a transaction that occurred on Thursday, September 19th. The shares were purchased at an average cost of 16.14 per share, with a total value of 249,443.70. Following the completion of the acquisition, the insider now directly owns 20,601,568 shares of the company’s stock, valued at approximately 332,509,307.52. The trade was a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last quarter, insiders purchased 99,630 shares of company stock valued at $1,585,113.

BlackRock Health Sciences Term Trust Stock Performance

Shares of NYSE BMEZ opened at 15.70 on Monday. BlackRock Health Sciences Term Trust has a fifty-two week low of 12.93 and a fifty-two week high of 16.59. The business has a 50 day moving average price of 15.87 and a two-hundred day moving average price of 15.49.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be given a dividend of $0.176 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 13.45%. The ex-dividend date of this dividend is Tuesday, October 15th.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.